| |
All manuscripts must be submitted online at http://ees.elsevier.com/jvir .
Questions related to the status of manuscripts
should be addressed to:
Stephanie Yoder
Publications Coordinator, JVIR
Society of Interventional Radiology
3975
Fair Ridge Drive, Suite 400 North
Fairfax, VA 22033
Telephone: 703.460.5592
Fax: 703.691.1855
E-mail: JVIR@SIRweb.org
The Journal of Vascular and Interventional Radiology (JVIR) is devoted to the timely publication of peer-reviewed clinical
and laboratory studies in the field of vascular and interventional radiology. JVIR is the official journal of the Society of Interventional
Radiology (SIR). Statements made in published articles are the responsibility of the authors and not that of JVIR or SIR.
These
instructions follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (N Engl J Med 1997; 336:309 or
see http://www.icmje.org/index.html ). Once accepted, manuscripts are copy edited to conform to JVIR's standards
and style. Accepted manuscripts become the property of JVIR and may not be published in whole or in part without the express written
permission of the author(s) and JVIR (see section below, Rights and Permissions).
Transfer of Copyright and Exclusive Submission
Agreements
As part of the submission process, authors will be required to complete an electronic copyright transfer form, certificate
of exclusive submission, and financial disclosure statement. For officers or employees of the U.S. government, JVIR recognizes
that works prepared as part of their official government duties are in the public domain, but they must still complete the relevant forms.
Authors will also be required to disclose whether submissions involve authors with financial interests in a company or organization and
a notation of the financial relationship will be included as a footnote on the first page of the article.
Manuscripts will only be
reviewed and accepted with the understanding that they are contributed solely to JVIR. Authors must be certain that no manuscript
on the same or similar material has been or will be submitted to another journal by themselves, their co-authors, or others at their
institution before their work appears in JVIR. The submission by authors of similar material to advertising, broadcast, or electronic
media must be indicated at the time JVIR receives the manuscript.
Permission to reproduce material from JVIR should
be made to:
Permissions
Global Rights Department
Elsevier Inc.
Oxford, UK
Phone: +1 215-239-3804 or +44 (0) 1865 843830
Fax: +44 (0) 1865 853333
E-mail: healthpermissions@elsevier.com
Journal authors retain rights for a large number
of author uses, including use by your employing institution or company. These rights are retained and permitted without the need to obtain
specific permission from Elsevier. For information about what author-uses are retained by the journal author, please visit:
http://www.elsevier.com/wps/find/authorsview.authors/authorsrights
Ethical Conduct of Studies
It is the author's responsibility to ensure that patient anonymity is carefully protected.
Authors from U.S. institutions must comply with all regulations of the Health Insurance Portability and Accountability Act (HIPAA) of
1996.
If an Institutional Review Board (IRB) exists at the institution(s) in which any study involving human subjects is conducted,
the investigators must obtain prior IRB approval. This requirement applies to prospective and retrospective studies (including technical
notes and case reports) that involve any direct interaction with patients OR evaluation or review of private information (eg, imaging
studies or chart reviews). See Valji K. IRB Approval--Who Needs It? J Vasc Interv Radiol 2002; 13:225-226.
If the IRB at the participating
institution does not require approval for the type of research being performed, a statement to this effect must be included in the manuscript.
If no IRB existed at the time the study was initiated, the authors must include a statement in the manuscript to this effect, as well
as a second statement that the principles of the Declaration of Helsinki (http://www.nihtraining.com/ohsrsite/guidelines/helsinki.html
) were followed. If a manuscript reports on the emergent use of a material or device not approved by the Food and Drug Administration
or accepted as standard practice, the authors must state that they obtained informed consent from the patient (when feasible) and reported
the case to the local IRB within 1 week of the event. This procedure is only valid for a single patient.
Manuscripts reporting research
involving animals must include a statement that either the protocol was approved by an institutional animal care board or that the animal
care complied with the "Principles of Laboratory Care" (formulated by the National Society for Medical Research) or the "Guide for the
Care and Use of Laboratory Animals" (National Institutes of Health).
Authorship
Any person listed as a manuscript author
should have made substantive intellectual contributions to the study as established by the International Committee of Medical Journal
Editors (ICMJE, www.icmje.org). All authors should meet all of the following
conditions with regard to the manuscript: (1) Substantial contributions to conception and design, or acquisition of data, or analysis
and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; and (3) final approval
of the version to be published.
Reporting Standards
In order to ensure consistency in reporting of results of clinical
research, the Society of Interventional Radiology has developed a number of reporting standards documents that authors should follow
when submitting manuscripts for consideration. Adherence to relevant reporting standards will be taken into account in the review process.
Links to these documents are given below. Alternatively, go to the www.JVIR.org
home page and click on the left-hand menu bar, Reporting Standards.
1. Sacks, D., McClenny, T.E., Cardella, J.F., et al. Society
of Interventional Radiology Clinical Practice Guidelines.
J Vasc Interv Radiol 2003; 14:199S-202.
2. Sacks, D., Marinelli, D.L.,
Martin, L.G., et al. General Principles for Evaluation of New Interventional Technologies and Devices. J Vasc Interv Radiol 2003;
14:391S-394.
3. Rundback, J.H., Sacks, D., Kent, K. C., et al. Guidelines for the Reporting of Renal Artery Revascularization in
Clinical Trials. J Vasc Interv Radiol 2003; 14:477S-492.
4. Recommended Reporting Standards for Vena Caval Filter Placement
and Patient Follow-Up. J Vasc Interv Radiol 2003; 14:427S-432.
5. Millward, S.F., Grassi, C.J., Kinney, T.B., et al., for the
Technology Assessment Committee of the Society of Interventional Radiology, Reporting Standards for Inferior Vena Caval Filter Placement
and Patient Follow-up: Supplement for Temporary and Retrievable/Optional Filters. J Vasc Interv Radiol 2005; 16:441-443.
6. Higashida,
R.T., Meyers, P.M., Phatouros, C.C., et al. Reporting Standards for Carotid Artery Angioplasty and Stent Placement. J Vasc Interv
Radiol 2004; 15:e1-24.
7. Sacks, D., Marinelli, D.L., Martin, L.G., et al. Reporting Standards for Clinical Evaluation of New Peripheral
Arterial Revascularization Devices. J Vasc Interv Radiol 2003; 14:395S-404.
8. Haskal, Z.J., Rees, C.R., Ring, E.J., Saxon, et
al. Reporting Standards for Transjugular Intrahepatic Portosystemic Shunts.
J Vasc Interv Radiol 2003; 14:419S-426.
9. Gray,
R.J., Sacks, D., Martin, L.G., et al. Reporting Standards for Percutaneous Interventions in Dialysis Access. J Vasc Interv Radiol
2003; 14:433S-442.
10. Silberzweig, J.E., Sacks, D., Khorsandi, A.S., et al. Reporting Standards for Central Venous Access. J Vasc Interv
Radiol 2003; 14:443S-452.
11. Goodwin, S.C., Bonilla, S.C., Sacks, D., et al. Reporting Standards for Uterine Artery Embolization
for the Treatment of Uterine Leiomyomata. J Vasc Interv Radiol 2003; 14:467S-476.
12. Patel, N., Sacks, D., Patel, R.I., et al. SIR Reporting Standards for the Treatment of Acute Limb Ischemia with Use of Transluminal Removal of Arterial Thrombus. J Vasc
Interv Radiol 2003; 14:453S-465.
13. Trial Design and Reporting Standards for Intraarterial Cerebral Thrombolysis for Acute Ischemic
Stroke. J Vasc Interv Radiol 2003; 14:493S-494.
14. Veith, F.J., Abbott, W.M., Yao, J.S.T., et al. Guidelines for Development
and Use of Transluminally Placed Endovascular Prosthetic Grafts in the Arterial System. J Vasc Interv Radiol 2003; 14:405S-417.
15. Goldberg, S. N., Grassi, C.J., Cardella, J.F., et al. Image-guided Tumor Ablation: Standardization of Terminology and Reporting
Criteria. J Vasc Interv Radiol 2005; 16:765-778.
16. Vedantham, S., Grassi, C.J., Ferral, H., et al. Reporting Standards for
Endovascular Treatment of Lower Extremity Deep Vein Thrombosis. J Vasc Interv Radiol 2006; 17:417-434.
17. Kundu A, Lurie F, Millward S, et al. Recommended Reporting Standards for Endovenous Ablation for the Treatment of Venous Insufficiency: Joint Statement of the
American Venous Forum and the Society of Interventional Radiology. J Vasc Interv Radiol 2007; 18:1073-1080.
18. Brown, Daniel
B., Gould, Jennifer E., Gervais, Debra A., et al. Transcatheter Therapy for Hepatic Malignancy: Standardization of Terminology and
Reporting Criteria. J Vasc Interv Radiol 2007; 18:1469-1478.
19. Clark, TWI, Millward, SF, Gervais, DA, et al. Reporting Standards
for Percutaneous Thermal Ablation of Renal Cell Carcinoma. J Vasc Interv Radiol 2009; 20:S409-S416.
20. Meyers, PM., Shumacher,
HC, Higashida, RT, et al. Reporting Standards for Endovascular Repair of Saccular Intracranial Cerebral Aneurysms. J Vasc Interv
Radiol 2009; 20:S435-S450.
21.Schumacher, HC, Meyers, PM, Higashida, RT, et al. Reporting Standards for Angioplasty and Stent-assisted
Angioplasty for Intracranial Atherosclerosis. J Vasc Interv Radiol 2009; 20:S451-S473.
22. Rose, SC, Dupuy, DE, Gervais, DA,
et al. Research Reporting Standards for Percutaneous Thermal Ablation of Lung Neoplasms. J Vasc Interv Radiol 2009; 20:S474-S485.
CONSORT Criteria
Beginning October 1, 2009, when submitting a manuscript, authors will be asked to upload the CONSORT
criteria and checklist. JVIR formally endorses the CONSORT (Consolidated Standards of Reporting Trials) Statement. The CONSORT Statement
contains criteria developed to improve the quality of published reports of randomized clinical trials. The current criteria consist of
a 22-item checklist that pertains to the various sections of a report of a clinical trial (Title, Abstract, Introduction, Materials and
Methods, Results, Discussion). The CONSORT criteria have been adopted by many leading medical journals as a template for reporting randomized
clinical trials. JVIR encourages clinical investigators to familiarize themselves with the criteria, voluntarily follow these guidelines
when reporting randomized clinical trials, and follow them as closely as possible for non-randomized trials. Beginning October 1st, when
submitting a manuscript reporting a randomized controlled trial, authors are strongly encouraged to upload the CONSORT criteria checklist
and flow diagram and to attach the completed checklist to their submission. These elements will not be mandatory initially. Although
the criteria apply strictly to randomized controlled trials, authors of other types of submissions may find the criteria helpful in the
development of a strong manuscript. For more information on the CONSORT Statement, please visit http://www.consort-statement.org/home/.
In addition to viewing the checklist and flow diagram, please also read the CONSORT Explanation and Elaboration document found on the
Web site, which explains and illustrates the principles underlying the CONSORT Statement.
Please note that when referring to the CONSORT
Statement, use any of the following journal article citations rather than referring to the CONSORT Statement Web site.
-
Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group
randomised trials. Lancet 2001; 357(9263):1191-1194.
- Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations
for improving the quality of reports of parallel-group randomized trials. JAMA 2001; 285(15):1987-1991.
- Moher D, Schulz KF,
Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann
Intern Med 2001; 134(8):657-662.
Also, since the CONSORT Statement should be read in conjunction with the CONSORT Explanation
and Elaboration Document, you should also cite:
- Altman DG, Schulz KF, Moher D, Egger M. Davidoff F, Elbourne D, G?tzsche
PC, Lang T. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001; 134(8):663-694.
Note to Authors from Non-English Speaking Countries
JVIR publishes manuscripts only in English. This
includes using the American variant of spelling and decimal points. To assist you in preparing your manuscript in its best possible form,
we recommend you take advantage of online resources provided by our publisher, Elsevier, Inc. Please visit "Language Editing" online
at www.elsevier.com/wps/find/authorsview.authors/languagepolishing.
Alternatively, you may contact the American Medical Writers Association (www.amwa.org);
the Council of Science Editors (www.councilscienceeditors.org;
click on Job Bank, then Manuscript Services), or the Society for Scholarly Publishing (www.sspnet.org;
click on Services Directory and choose the category, Copy Editing).
Types of Manuscripts
JVIR publishes several
types of articles, each of which has a distinct format:
• Clinical Studies and Laboratory Investigations are
the central focus of the Journal and are based on original clinical or experimental studies. The complete format is described under the
Manuscript Preparation section.
• Brief Reports include descriptions of a new or modified interventional procedure
or device and small clinical studies or case reports. A brief, one-paragraph abstract (fewer than 100 words) should be included. In general,
limit the paper to six pages of text, 15 references, and no more than eight figure parts.
• IR Safety Rounds are safety/medical
error submissions. No abstract is needed. The format should include the following:
- • Clinical case: Brief
description of the clinical event, including patient outcome. (Several similar events with the same base etiology may be included, if
they reinforce the theme, demonstrate variations on the theme, or indicate that the event is not rare.) Where appropriate, illustrations
of the hazard or of the resultant injuries may be helpful to the reader. The individuals and institutions involved should not be identified
or identifiable from the text or context of the vignette.
• What happened and why did it happen? One or more paragraphs
describing the chain of events that permitted the medical error or safety issue to occur and affect the patient or staff member. One
or more paragraphs stating the root cause of the safety issue or medical error.
• Discussion: Brief paragraph providing
background for the reported event. Have similar events been reported? How frequently do they occur? One or more paragraphs should describe
the corrective steps implemented following the event. What preventive measures should be in place to avoid recurrence? Relevant guidelines/standards
developed by SIR and other societies should be cited. Where appropriate, illustrations of preventive measures may be included. Length
should be no more than six manuscript pages, with 10 references, maximum. No more than two figures should be submitted.
• SIR Clinical Practice Series are brief clinical vignettes with evidence-based discussion of management options. Clinical
problems will be medical management issues, and the decision for procedure or details of procedures are not to be discussed. The length
of the article should be limited to approximately 3 pages of submitted text. May include 1-2 tables, figures, or images. The format is
as follows:
-
• Abstract: Unstructured; 100 words or fewer
• Clinical Presentation: Patient
presentation, history, physical exam, lab findings, relevant imaging findings. The clinical presentation will end with a one sentence
summary statement of the clinical question to be addressed.
• Discussion: Two to three paragraph review of relevant
literature and published guidelines for management of the medical question. This discussion should be heavily evidence based.
• Management Decision: Brief paragraph providing the assessment and plan for managing the medical problem.
• Key
Points: This may be a list of bullet points, a flow chart, a table, or other guideline suitable for copying or clipping from the
journal for future reference.
• References: 3-5 references
• Letters to the Editor
can be used to offer commentary on any material published in JVIR. Letters may also be used to convey material of more general
interest to the interventional radiology community. On occasion, the Editor may offer such space for submitted case reports that do not
receive high enough priority for publication as such. Letters should be no longer than three pages with no more than four references.
Only one figure (with no more than four figure parts) can be submitted. Letters to the Editor are accepted for publication at the discretion
of the Editor and may be copyedited for content and length. Letters that relate to a published article will be published pending response
from the original article's author.
• Book Reviews are submitted through the office of the Book Review Editor. Please
contact Diane Washington at the office of Dr. Alan H. Matsumoto, MD, FSIR (ddw3u@virginia.edu)
• Review Articles
are generally invited by the Editor. Specific instructions are provided at the time of invitation. The Editor will accept unsolicited
review articles.
Manuscript Preparation
The preferred word processing program is Microsoft Word. Manuscripts must be written
with 12 point font, double-spaced throughout (including tables, references, and figure legends), and have at least 3-cm margins. The
text should be ragged right (no right justification). Embedded instructions (eg, italics, underlines, boldface) should not be used or
should be kept to a minimum. Do not use coding for centering. Insert only one space after punctuation marks. Sequential page numbering
should begin with the text. The order of sections is Abstract, Text, References, Tables, and Figure Legends. To ensure blinded peer-review,
no direct references to the author(s) or institution(s) of origin should be made anywhere in the text or figures.
• Title
Page: Include a title page as a separate document. List all author affiliations, any conflicts of interest and financial disclosures,
and whether the material was presented at an SIR Annual Meeting. Also, please list any acknowledgments.
- • Acknowledgments:
On the title page, list any significant contributors to the conduct of the study or preparation of the manuscript other than your co-authors.
Authors are responsible for obtaining permission from persons acknowledged for support that is other than technical, secretarial, or
financial
• Abstract: The abstract for original clinical and laboratory investigations should be no longer
than 250 words and should include Purpose, Materials and Methods, Results, and Conclusion. For brief reports and review articles, the
abstract is a short (fewer than 100 words) unstructured paragraph. Remember that many readers will only come to know the authors' work
through the abstract. Actual data (with statistical significance) should be included in the Results. The conclusions should be drawn
directly from the results of the study. Note that the conclusion will be used as a summary statement of your work in the printed Table
of Contents.
• Introduction: Provide a brief summary (usually less than one page) of background material to set the
stage for your paper. This section should end with a succinct statement of the purpose of your study.
• Materials and Methods:
Describe the nature of the subjects, methods of selection, materials (including manufacturers' names and locations-city and state or
country), and all procedures. The characteristics of study group(s) (such as sex distribution, mean age, underlying medical problems)
should be included in this section. References should be made to established methods that have been published. New or substantially modified
methods should be described, supported with rationale, and critically evaluated for real and potential limitations. This section should
conclude with a description (and references and names of computer software packages, when appropriate) of all statistical methods used
to analyze the data.
• Results: Report of data and observations should be in logical sequence in the text, tables and
illustrations. Data given in tables should not be repeated in the text. Complex reports may require subheadings in this section.
• Discussion: Consider new and important aspects of the study and conclusions that can be drawn directly from your data. Include
implications of findings, and relate observations to other relevant studies. Include a separate paragraph that outlines the limitations
of your study. Avoid claiming priority, alluding to work that has not been completed, or making unqualified statements not supported
by your data. Recommendations, when appropriate, should be made.
References: Number the references in the order in which
they appear in the text (including references in tables at the site where they are mentioned in the text). Reference numbers appear on
line within parentheses (not bracketed, not superscripted). With the exception of review articles, no more than 35 to 40 references should
be made. The abbreviations used for periodicals follow the style of Index Medicus. Unpublished data are not cited in the reference
list but cited parenthetically in the text. For individuals using computer bibliographies (eg, End Note), JVIR style is modified
Vancouver (exceptions to Vancouver include: give the names of all authors up to six; if there are more than six authors, use the first
three names followed by et al.; use minimal punctuation, with no periods for author initials; do not include issue numbers; use complete
page ranges). The use of references for which no English translation or abstract is available is acceptable only if this is the sole
source of primary information relevant to the submitted manuscript. However, given the difficulty such references pose to reviewers and
readers, authors are asked to limit their use to the extent possible.
o For journal articles with six or fewer authors, list surnames
and initials of all authors, such as:
- Gupta S, Madoff DC. Image-guided percutaneous needle biopsy in cancer diagnosis and
staging. Tech Vasc Interv Radiol 2007; 10:88-101.
o Note that inclusive page numbers are required. When seven or more authors
are listed, only the first three names need to be identified, followed by "et al," such as:
- Larson AC, Wang D, Atassi B, et
al. Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma-feasibility of initial translation.
Radiol 2008; 234:964-971.
o Abstracts, editorials, and letters to the editor should be noted as such. For book references,
the authors of the chapter, chapter title, editor(s), book title, edition, city of publication, publisher, year of publication, and inclusive
pages must be provided:
- Nemcek AA, Resnick S. Case 2: Swollen leg. In: Brown DB, ed. 2008 Case-Based Review Monograph. Fairfax:
Society of Interventional Radiology, 2008; 7-12.
o For papers presented at a meeting but not published, these oral presentations
take the following form:
- Oppenheimer JD, Ryu RK, Kasuganti D, et al. Surgically proven malignancy in thyroid US-guided FNA
biopsies interpreted as nondiagnostic, malignant, and benign. Presented at the 33rd Annual Scientific Meeting of the Society of Interventional
Radiology; March 19, 2008; Washington, DC.
o For citation to material on a Web site, use the following:
- Raymond
EB, Grassi, CJ, Edward IB, et al. Practice guideline for the performance of physiologic evaluation of extremity arteries. J Vasc Interv
Radiol 2007; 18:1203-1206. Available at http://www.sirweb.org/clinical/outside.shtml . Accessed April 21, 2008.
o If reference is made in the text to personal communication (oral or written) as a source of information, a signed statement is required
from the source. Please be certain that all references are accurate and complete.
Tables: Tables should have a title, be referenced
in the text, and numbered sequentially using Arabic numerals. All abbreviations used in the table should be explained in a footnote.
No vertical lines or shading should be included in the tables, and excessive use of horizontal lines within the table should be avoided.
Construct tables using the table creating and editing feature of your word processing program. Do not use Excel or comparable spreadsheets.
Do not embed tables within the body of the manuscript.
Figure Captions: A caption must be supplied for each illustration and
should not duplicate text material. Figure captions should appear on one or more pages separate from the text.
Illustrations.
Illustrations/figures should be submitted electronically. When submitting the figures electronically, please use an EPS or TIF file format.
Graphics software such as Photoshop and Illustrator should be used to create art. Figures submitted using presentation software such
as PowerPoint, CorelDraw, or Harvard Graphics are not acceptable. Color images need to be saved as CMYK, at least 300 dots per inch
(dpi). Grayscale images should be at least 300 dpi. Line art (black and white or color) and combinations of grayscale and line art should
be at least 300 dpi. Make sure that the figure number is marked clearly on the figure or part of the electronic file name (ie, Figure1.tif).
Please note that once you create digital art at low resolution, you cannot adjust it. You must create your art at the proper resolution
(300 dpi) to begin with. For step-by-step instructions and screenshots on how to create your art correctly the first time, go to www.elsevier.com/artworkinstructions
Your figures can move into review even if they are not up to production standards; however,
you should be prepared to provide better quality figures should JVIR express interest in your manuscript.
Figures must be cited
in the text and numbered in order of first mention. Color illustrations are published at the discretion of the editorial office. Please
note that the figures in the online version of the Journal will be reproduced in color.
Legends must be provided for all
illustrations. The legend should not appear anywhere on the figure. If a figure has been published previously, the legend must give full
credit to the original source.
Units and Abbreviations: Laboratory values and radiation measurements should be given in the
International System of Units (SI). (Now read this: the SI units are here. JAMA 1986; 255:2329-2339; SI units in radiation protection
and measurements, NCRP report no. 82, August 1985.) Standard abbreviations (eg, TIPS, PTA) are permissible. Laboratory slang and clinical
jargon should be avoided. Keep unique abbreviations to a minimum. Spell out the full term for each abbreviation at first use in the text
unless it is a standard unit of measure.
Summary of Requirements for Halftones: Radiographs, Photographs or Scanned Images
Basic parameters
- File Type: TIF
Resolution: 300 dpi
Color mode: grayscale or CMYK
Greatest dimension (inches): 7"
Greatest dimension (pixels): 2100
File storage size (approximate)
- Grayscale: 1-4 MB
CMYK: 4-16 MB
Summary of Requirements for Line Art: Diagrams, Drawings and Graphs
Basic parameters
- File Type: TIFF or EPS
Resolution: 1200 dpi
Color mode: Bitmap, grayscale or CMYK
Greatest dimension (inches): 7"
Greatest dimension (pixels): 8400
File storage size (approximate)
- Grayscale: 24 MB
Bitmap: 3 MB
Additional material for
electronic publication only: Under exceptional or special circumstances, JVIR will allow publication of additional tables,
figures, or text (eg, methodology, explanations of analysis, etc) in the electronic version of the published manuscript. This material
will not be included in the print version but a reference to its availability online will be present in the print version. The Editor
would like to emphasize that such additional material will have to meet strict criteria to be included in the electronic version; such
material may be used to complement the data in the printed version. If deemed by the authors or Editor as crucial to the interpretation
of the manuscript, this material should be included as part of the printed version of the manuscript. Please mark clearly in the submitted
manuscript that this is additional information to be published electronically. The electronic version should not be used as a repository
for redundant or unnecessary data.
Video clips for electronic version: We will accept relevant video clips with accepted
manuscripts for viewing in our online version of JVIR.
Authors who are unable to provide an electronic version of their manuscript
or have other circumstances that prevent online submission must contact the Journal staff prior to submission to discuss alternate options.
The publisher and editor regret that they are not able to consider submissions that do not follow these procedures.
Manuscript
Submission
All new manuscripts must be submitted through the JVIR online submission and review Web site at http://ees.elsevier.com/jvir
. Authors are requested to submit the text, tables, and artwork in electronic form (not as a PDF) to this address. Authors will also
be required to complete an electronic copyright transfer form, certificate of exclusive submission, and financial disclosure statement.
Authors are highly encouraged to suggest three or more potential reviewers for their manuscript, with complete contact information.
Submission items include:
• a cover letter (save as a separate file for upload)
• a title page
• the blinded
manuscript (including abstract, main text, references, and table/figure legends),
• tables
• figures
•
Revised manuscripts should also be accompanied by a unique file (separate from the cover letter) with responses to reviewers' comments.
The preferred order of files is as follows:
• cover letter
• response to reviews (revised manuscripts only)
•
manuscript file(s)
• table(s)
• figure(s)
Files should be labeled with appropriate and descriptive file names
(eg, SmithText.doc, Fig1.eps, Table3.doc). Upload text, tables, and graphics (figures) as separate files. (You can compress multiple
figure files into a Zip file and upload that in one step; the system will then unpack the files and prompt you to name each figure.)
Do not import figures or tables into the text document and do not upload your text as a PDF.
Authors can contact Elsevier with technical
queries at: AuthorSupport@Elsevier.com.
Page Proofs and Corrections
Corresponding authors will receive electronic
page proofs to check the copyedited and typeset article before publication. Portable document format (PDF) files of the typeset pages
will be sent to the corresponding authors by e-mail, along with complete instructions for downloading. PDFs will also be annotated, thus
allowing authors to place comments directly on the PDF file before sending to the Journal Manager via e-mail within 48 hours of receipt.
(To access and work within the PDF, you will need to have Adobe Acrobat Reader software). If you are unable to add annotations to the
PDF, please indicate what the corrections are via e-mail to Journal Manager Rachel Sampson at r.sampson@elsevier.com or
mark the corrections and any other comments (including replies to queries) on a printout of the PDF file and fax to Rachel's attention
at 212.633.3853. Changes that have been made to conform to journal style will stand if they do not alter the author's meaning. Changes
that are stylistic or are a reworking of previously accepted material will not be allowed. It is the author's responsibility to ensure
that there are no errors in the proofs.
Rights and Permissions
Direct quotations, tables, or illustrations that have appeared
in copyrighted material must be accompanied by written permission for their use from the copyright owner and original author along with
complete information as to the source. Photographs of identifiable persons must be accompanied by signed releases, showing informed consent.
Articles appear in both the printed and online versions of JVIR and wording of the release should specify permission in all forms
and media. Failure to obtain electronic permission rights may result in the images not appearing in the online version.
Publication
of Supplements
Requests for publication in JVIR are reviewed by the Editor with advice from members of the JVIR
Editorial Board. To be considered for publication, such supplements must have educational value and be useful to the general readership.
The topic must be treated in an impartial, unbiased manner. JVIR will not consider publication of symposium proceedings for which JVIR has not participated in the planning process. The final decision to publish a symposium as a supplement to JVIR rests
with the JVIR Editor and is based on the specific topic, the supplement editors, and the contributors.
Once a decision has
been made to publish a symposium as a supplement to JVIR, the individual manuscripts undergo review. Individual authors are responsible
for their own contributions, with overall quality the responsibility of the guest editor. All manuscripts are reviewed by the JVIR
Editor, who retains complete and final editorial control of all supplement material, including the right to delete or add any additional
material.
Updated November 2009
|
| |
|
